Larry Mathis Financial Planning, LLC
Source: SEC Form 13F · as of Mar 2026Larry Mathis Financial Planning, LLC holds 13 biotech & pharma companies tracked by BioSniper, totaling $7.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$7.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 6,424 | $1.6M |
| MRKMerck & Co., Inc. | 8,803 | $1.1M |
| NVSNovartis AG | 5,575 | $852K |
| ELVElevance Health Inc. | 2,790 | $817K |
| GILDGILEAD SCIENCES, INC. | 4,697 | $655K |
| BMYBRISTOL MYERS SQUIBB CO | 8,195 | $497K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 962 | $430K |
| NVONovo Nordisk A/S | 11,029 | $405K |
| MOHMolina Healthcare Inc | 2,244 | $299K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,037 | $281K |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 14,187 | $263K |
| SNYSanofi | 4,486 | $216K |
| MNKDMANNKIND CORP | 17,119 | $42K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.